Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1376 to 1400 of about 5861

Previous 25

Website Changes

09/29/2017

I’m dying of brain cancer. I prepared to end my life. Then I kept living.

09/27/2017

09/24/2017

Combination of Optune® with Temozolomide Demonstrates Unprecedented Five-Year Survival for Newly Diagnosed Glioblastoma Patients

09/24/2017

How the poliovirus can be used to battle lethal cancers

09/19/2017

New math developments lead to more improved brain cancer treatment

09/14/2017

Treatment nonexistent for some glioblastoma patients

09/11/2017

DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme

09/11/2017

"Treatment Options for Glioblastoma and other Gliomas" Ben Williams` Aug 2017 Update

09/10/2017

How a Dallas reporter pushed the FDA for a new approach to treating brain cancer

09/09/2017

NCCN Announces First Patient Dosed in NCCN-Peregrine Pharmaceuticals Collaborative Study of Bavituximab

09/07/2017

Curtana Pharmaceuticals Successfully Completes Pre-IND Submission for CT-179 for the Treatment of Malignant Gliomas

09/06/2017

Zika Virus Kills Brain Tumor Cells, Researchers Find

09/06/2017

09/01/2017

Lymphoma Patient’s Brain Tumor Disappeared After She Received JCAR017, Study Reports

09/01/2017

Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields

08/27/2017

STELLAR trial for Recurrent Anaplastic Astrocytoma

08/27/2017

OPTUNE OPEN HOUSE - NY Sept 9

08/18/2017

Reengineering Immune System Cells to Fight Glioblastoma

08/16/2017

VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme

08/16/2017

CHOP to lead new pediatric data resource center for research in childhood cancer, birth defects

08/15/2017

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas

08/15/2017

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas

08/15/2017

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas

08/14/2017

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.

08/14/2017

Options to Treat a Glioblastoma

Our privacy / cookie policy has changed.
Click HERE to read it!